Victory Capital Management
BLFS icon

Victory Capital Management’s BioLife Solutions BLFS Stock Holding History

Victory Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-218,962
Closed -$5.68M – 2479
2024
Q4 		$5.68M Buy
218,962
+177,028
+422% +$4.41M 0.01% 1237
2024
Q3 		$1.05M Sell
41,934
-42,851
-51% -$1.01M ﹤0.01% 1758
2024
Q2 		$1.82M Sell
84,785
-11,078
-12% -$215K ﹤0.01% 1463
2024
Q1 		$1.78M Hold
95,863
– – ﹤0.01% 1492
2023
Q4 		$1.56M Sell
95,863
-21,589
-18% -$275K ﹤0.01% 1520
2023
Q3 		$1.62M Buy
117,452
+145
+0.1% +$2.29K ﹤0.01% 1460
2023
Q2 		$2.59M Sell
117,307
-25,802
-18% -$543K ﹤0.01% 1329
2023
Q1 		$3.11M Sell
143,109
-45,819
-24% -$1.03M ﹤0.01% 1301
2022
Q4 		$3.44M Sell
188,928
-27,010
-13% -$558K ﹤0.01% 1290
2022
Q3 		$4.91M Buy
215,938
+3,893
+2% +$83.3K 0.01% 1247
2022
Q2 		$2.93M Sell
212,045
-30,653
-13% -$450K ﹤0.01% 1367
2022
Q1 		$5.27M Sell
242,698
-44,831
-16% -$1.18M 0.01% 1284
2021
Q4 		$10.7M Buy
287,529
+19,639
+7% +$843K 0.01% 1108
2021
Q3 		$11.3M Buy
267,890
+41,658
+18% +$2.01M 0.01% 1060
2021
Q2 		$10.1M Sell
226,232
-6,545
-3% -$231K 0.01% 1128
2021
Q1 		$8.38M Buy
232,777
+157,330
+209% +$6.22M 0.01% 1191
2020
Q4 		$3.01M Buy
75,447
+4,039
+6% +$138K ﹤0.01% 1382
2020
Q3 		$2.07M Buy
71,408
+61,226
+601% +$1.32M ﹤0.01% 1429
2020
Q2 		$166K Sell
10,182
-2,074
-17% -$28.6K ﹤0.01% 2321
2020
Q1 		$116K Buy
12,256
+7,598
+163% +$104K ﹤0.01% 2496
2019
Q4 		$75K Buy
4,658
+327
+8% +$5.32K ﹤0.01% 2587
2019
Q3 		$72K Buy
+4,331
New +$81.3K ﹤0.01% 2548

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Victory Capital Management's BLFS Position: Q1 2025 in Review

Victory Capital Management sold out of BioLife Solutions (BLFS) in Q1 2025, closing a stake of 218,962 shares — an estimated $5.68M sold.

Victory Capital Management first reported a position in BLFS in Q3 2019 and held it in 22 quarters. The position peaked at $11.3M in Q3 2021. 188 funds tracked by Wall St. Rank hold BLFS as of Q1 2025.

  • Victory Capital Management reported no remaining BioLife Solutions position as of Q1 2025 after selling out during the quarter.
  • Victory Capital Management sold 218,962 BioLife Solutions shares in Q1 2025, an estimated $5.68M.
  • Victory Capital Management first reported a position in BioLife Solutions in Q3 2019 and held it in 22 quarters.
  • Victory Capital Management's BioLife Solutions position peaked at $11.3M in Q3 2021.
  • 188 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2025.

Based on Victory Capital Management's 13F filing for Q1 2025, filed 2 May 2025.